Veterinary Medicines

Aviffa RTI

Authorised
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
Download as PDF

Product identification

Medicine name:
Aviffa RTI
Active substance:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
Target species:
  • Chicken
  • Turkey
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
    2.30
    log10 50% tissue culture infectious dose
    /
    1.00
    Actuation
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Available in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Portugal Unipessoal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • MERIAL Laboratoire Porte des Alpes
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 242/88
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 15/06/2023
Updated on: 17/06/2023
Download